Emerging Infectious Disease ISSN: 1080-6059

Invasive Cryptococcosis and Adalimumab Treatment

Juan P. Horcajada*

, Jose L. Peña*, Víctor M. Martínez-Taboada*, Trinitario Pina*, Isabel Belaustegui*, María Eliecer Cano*, Daniel García-Palomo*, and M. Carmen Fariñas*

Author affiliations: *University Hospital Marqués de Valdecilla, Santander, Spain;

Main Article

Figure

Histiocytic granuloma with lymphocytes and multinucleated giant cells and an encapsulated intracytoplasmic mucicarmine-positive structure identified as a Cryptococcus sp. (arrow) (hematoxylin and eosin– and Mayer mucicarmine–stained, magnification 400×).

Figure. Histiocytic granuloma with lymphocytes and multinucleated giant cells and an encapsulated intracytoplasmic mucicarmine-positive structure identified as a Cryptococcus sp. (arrow) (hematoxylin and eosin– and Mayer mucicarmine–stained, magnification 400×).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.